Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
19 Resultado(s)
Ensayo clínico en reclutamiento
= 
; Ensayos clínico en curso
= 
; Financiado por un miembro del IRDiRC = 
; Miembro de una ERN = 
Ensayo(s) clínico(s) nacional(es)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) (Phase 2) - AT
Institution: Information not provided - AT
ESTADOS UNIDOS
Illinois
CHICAGO
An Open Label Extension, Multi-Center, Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa (Terminated) - US
Children's Hospital of Chicago
FRANCIA
OCCITANIE
TOULOUSE
EBTox : Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study (Phase II-III)
CHU de Toulouse - Hôpital Larrey
Centre de référence des maladies rares de la peau
ITALIA
LOMBARDIA
MILANO
An Open Label Multi-Center Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa (phase III) - IT
IRCCS Ca' Granda Ospedale Maggiore Policlinico - Padiglione De Marchi
U.O.S. di Infettivologia Pediatrica
ALEMANIA
Niedersachsen
HANNOVER
EASE study: Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa -DE-
Auf der Bult - Kinder- und Jugendkrankenhaus
Pädiatrische Dermatologie und Allergologie
AUSTRIA
SALZBURG
SALZBURG
EASE: Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa - AT
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
EB-Haus Austria
BELGICA
VLAAMS BRABANT
LEUVEN
EASE study: Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa - BE
UZ Leuven - Campus Gasthuisberg
Reference centre for inherited Epidermolysis Bullosa
ESPAÑA
Andalucía
SEVILLA
Estudio EASE: Estudio de fase III, doble ciego, aleatorizado, controlado con vehículo y con un seguimiento abierto de 24 meses sobre la eficacia y la seguridad de Oleogel-S10 en pacientes con epidermólisis ampollosa hereditaria
Hospital Viamed Santa Ángela de la Cruz
Servicio de Dermatología
ESPAÑA
Cataluña
BARCELONA
Estudio EASE: Estudio de fase III, doble ciego, aleatorizado, controlado con vehículo y con un seguimiento abierto de 24 meses sobre la eficacia y la seguridad de Oleogel-S10 en pacientes con epidermólisis ampollosa hereditaria
Hospital Universitari Vall d'Hebron
Servicio de Cirugía Plástica y Quemados
ESPAÑA
Cataluña
ESPLUGUES DE LLOBREGAT
Estudio EASE: Estudio de fase III, doble ciego, aleatorizado, controlado con vehículo y con un seguimiento abierto de 24 meses sobre la eficacia y la seguridad de Oleogel-S10 en pacientes con epidermólisis ampollosa hereditaria
Hospital Sant Joan de Déu Barcelona
Servicio de Dermatología
ESPAÑA
Madrid
MADRID
Estudio EASE: Estudio de fase III, doble ciego, aleatorizado, controlado con vehículo y con un seguimiento abierto de 24 meses sobre la eficacia y la seguridad de Oleogel-S10 en pacientes con epidermólisis ampollosa hereditaria
Hospital Universitario La Paz
Servicio de Dermatología infantil
IRLANDA
County Dublin
DUBLIN
EASE study: Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow up of Oleogel S10 in Patients with Inherited Epidermolysis Bullosa - IE
Children's Health Ireland @ Crumlin
Dermatology Department
IRLANDA
County Dublin
DUBLIN
EASE study: Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow up of Oleogel S10 in Patients with Inherited Epidermolysis Bullosa - IE
St James's Hospital
Dermatology Department
REINO UNIDO (EL)
Greater Manchester
ADDRESS: NOT PROVIDED - UK
EASE study: Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow up of Oleogel S10 in Patients with Inherited Epidermolysis Bullosa -GB
Institution: Information not provided - UK
SUIZA
Suisse Alémanique
BERN
EASE study: Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow up of Oleogel S10 in Patients with Inherited Epidermolysis Bullosa - CH
University Hospital Inselspital
Poliklinik für Dermatologie
Ensayo(s) clínico(s) multinacional(es)
ESTADOS UNIDOS
New Jersey
PARSIPPANY
An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)
Castle Creek Pharmaceuticals LLC
ESTADOS UNIDOS
North Carolina
DURHAM
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
DELIVERS Study: An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)
Institution: Information not provided - US
IRLANDA
County Dublin
ADDRESS: NOT PROVIDED - IE